Cerebral venous thrombosis is associated with major vessel disease in Behcet's syndrome

被引:58
作者
Tunc, R
Saip, S
Siva, A
Yazici, H
机构
[1] Selcuk Univ, Meram Sch Med, Dept Internal Med, Div Rheumatol, Konya, Turkey
[2] Cerrahpasa Med Sch, Div Rheumatol, Dept Internal Med, Behcets Syndrome Res Ctr, Istanbul, Turkey
关键词
D O I
10.1136/ard.2003.018515
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To examine the association between the type of central nervous system (CNS) involvement (parenchymal disease and cerebral venous thrombosis (CVT)) and extra-cranial large vessel events, mainly venous thrombosis, in Behcet's syndrome (BS). Methods: Conventional venous angiograms, Doppler ultrasonography, computed tomography, and MR angiography were used to study 88 patients with BS, with (n = 88) and without ( n = 80) CNS disease for the presence of major vessel disease. Results: Major vessel involvement among the male patients with and without CNS disease (21/73 (29%) v 18/80 (23%), respectively) showed no significant differences (p = 0.374). When patients with CNS disease were stratified according to the type of CNS involvement, 7/11 (64%) patients with CVT had major vessel disease compared with 15/77 (19%) patients with parenchymal disease (p = 0.004). The mean (SD) age of onset of CVT (23.1 (8.8) years) among the male patients was significantly earlier than among the men with parenchymal disease (32.0 (7.5); p = 0.002). Conclusions: CVT in BS was strongly associated with peripheral major vessel disease and occurred earlier in the disease course than the parenchymal type of CNS disease. As superficial thrombophlebitis also occurs more frequently in patients with major vessel disease in BS, this may suggest a common pathogenic mechanism.
引用
收藏
页码:1693 / 1694
页数:2
相关论文
共 14 条
[1]   Clinical patterns of neurological involvement in Behcet's disease:: evaluation of 200 patients [J].
Akman-Demir, G ;
Serdaroglu, P ;
Tasçi, B .
BRAIN, 1999, 122 :2171-2181
[2]   Seven-year follow-up of neurologic involvement in Behcet syndrome [J].
AkmanDemir, G ;
BaykanKurt, B ;
Serdaroglu, P ;
Gurvit, H ;
Yurdakul, S ;
Yazici, H ;
Bahar, S ;
Aktin, E .
ARCHIVES OF NEUROLOGY, 1996, 53 (07) :691-694
[3]  
Hadfield MG, 1997, CLIN NEUROPATHOL, V16, P55
[4]  
KOC Y, 1992, J RHEUMATOL, V19, P402
[5]  
Krause I, 1999, CLIN EXP RHEUMATOL, V17, P347
[6]   The long-term mortality and morbidity of Behcet syndrome - A 2-decade outcome survey of 387 patients followed at a dedicated center [J].
Kural-Seyahi, E ;
Fresko, I ;
Seyahi, N ;
Ozyazgan, Y ;
Mat, C ;
Hamuryudan, V ;
Yurdakul, S ;
Yazici, H .
MEDICINE, 2003, 82 (01) :60-76
[7]  
MUFTUOGLU AU, 1986, ROYAL SOC MED SERVIC, V103
[8]   NEUROLOGIC INVOLVEMENT IN 7 PATIENTS WITH BEHCETS DISEASE [J].
ODUFFY, JD ;
GOLDSTEIN, NP .
AMERICAN JOURNAL OF MEDICINE, 1976, 61 (02) :170-178
[9]   NEUROLOGIC INVOLVEMENT IN BEHCETS SYNDROME - A PROSPECTIVE-STUDY [J].
SERDAROGLU, P ;
YAZICI, H ;
OZDEMIR, C ;
YURDAKUL, S ;
BAHAR, S ;
AKTIN, E .
ARCHIVES OF NEUROLOGY, 1989, 46 (03) :265-269
[10]   BEHCET DISEASE (BEHCET SYNDROME) [J].
SHIMIZU, T ;
EHRLICH, GE ;
INABA, G ;
HAYASHI, K .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1979, 8 (04) :223-260